Farnum Rhonda — SEC insider filings
SEC reporting owner CIK 1898490. 39 insider filings on record with FilingPulse; latest filed 2026-09-24.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2021-12-16 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 27 legs across 17 filings — 152,428 shares, $2,119,505 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 15,534 shares @ $18.75 ($291,252) in Theravance Biopharma, Inc., filed 2025-12-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | SVP, COMM & MEDICAL AFFAIRS | 39 | — | 27 legs · 152,428 sh · $2,119,505 | 28 |
Insider filings — Farnum Rhonda
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Disposition to issuer (D): 124,414 · Disposition to issuer (D): 89,062 · Disposition to issuer (D): 150,000 (derivative) | EDGAR |
| 2026-09-17 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 3,329 @ $17.03 · Sale (S): 3,328 @ $17.03 · Sale (S): 6,657 @ $17.03 | EDGAR |
| 2026-08-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 5,667 @ $16.95 | EDGAR |
| 2026-06-17 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 3,329 @ $16.39 · Sale (S): 3,328 @ $16.38 · Sale (S): 6,657 @ $16.39 | EDGAR |
| 2026-05-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 5,678 @ $16.55 | EDGAR |
| 2026-04-03 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 18,750 @ $0 | EDGAR |
| 2026-03-18 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 7,767 @ $13.92 · Sale (S): 15,534 @ $14 · Sale (S): 7,766 @ $13.92 | EDGAR |
| 2026-02-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 13,929 @ $19.66 | EDGAR |
| 2025-12-05 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 7,767 @ $18.75 · Sale (S): 7,766 @ $18.75 · Sale (S): 15,534 @ $18.75 | EDGAR |
| 2025-11-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 9,060 @ $17.90 | EDGAR |
| 2025-08-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 9,096 @ $13.39 | EDGAR |
| 2025-07-16 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 682 @ $11.39 · Sale (S): 5,318 @ $11.39 · Sale (S): 4,000 @ $11.39 | EDGAR |
| 2025-06-04 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 24,000 @ $11 | EDGAR |
| 2025-05-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 9,120 @ $9.45 | EDGAR |
| 2025-04-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 4,000 @ $9 | EDGAR |
| 2025-03-04 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 75,000 @ $0 | EDGAR |
| 2025-02-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 5,283 @ $0 · Tax withholding (F): 15,810 @ $9.66 | EDGAR |
| 2025-01-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 4,000 @ $9 | EDGAR |
| 2024-11-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 9,178 @ $9.97 | EDGAR |
| 2024-11-13 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 4,000 @ $9 | EDGAR |
| 2024-08-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 9,222 @ $8.22 | EDGAR |
| 2024-07-12 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 4,000 @ $9 | EDGAR |
| 2024-05-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 9,268 @ $9.10 | EDGAR |
| 2024-04-04 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 37,500 @ $0 | EDGAR |
| 2024-02-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 18,219 @ $8.92 · Sale (S): 1,254 @ $8.71 | EDGAR |
| 2023-11-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 7,982 @ $10.37 · Sale (S): 1,378 @ $10.29 | EDGAR |
| 2023-08-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 1,807 @ $9.47 | EDGAR |
| 2023-08-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 10,460 @ $9.70 | EDGAR |
| 2023-06-12 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 1,790 @ $11.13 | EDGAR |
| 2023-05-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 5,567 @ $11.21 | EDGAR |
| 2023-03-13 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 4,000 @ $10.20 | EDGAR |
| 2023-03-03 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 75,000 @ $0 | EDGAR |
| 2023-02-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 7,119 @ $10.44 | EDGAR |
| 2022-11-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 23,268 @ $10.85 | EDGAR |
| 2022-08-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 10,413 @ $9.34 | EDGAR |
| 2022-05-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 2,200 @ $8.74 · Sale (S): 1,081 @ $8.93 | EDGAR |
| 2022-03-02 | 4 | Theravance Biopharma, Inc. (TBPH) | Sale (S): 2,356 @ $10.16 | EDGAR |
| 2022-02-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 11,824 @ $9.61 | EDGAR |
| 2021-12-16 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 27,500 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-12-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1898490 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs